CoChat

TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type response

Open access
Sioud, Mouldy, Fløisand, Yngvar · 2007 · European Journal of Immunology
Cited by 83

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

We recently reported that human bone marrow hematopoietic CD34+ progenitors express functional Toll‐like receptors (TLR) and can differentiate into myeloid cells just by stimulation with resiquimod (R848), a specific agonist for TLR7/8. However, the mechanisms by which R848 induces cell differentiation, the effects of other TLR agonists and the functionality of the differentiated cells are not known. Comparable to R848, loxoribine (a TLR7 agonist) and Pam 3 CSK 4 (a TLR2 agonist) induced cytokine production and cell differentiation along the myeloid lineage. R848 and loxoribine were more effective than Pam 3 CSK 4 at inducing the lineage‐negative (CD11c+ CD14–) dendritic cells (DC), whereas Pam 3 CSK 4 was more effective at inducing CD11c+ CD14+ monocytes. Both cell subsets expressed CD80/CD86 and HLA‐DR molecules; however, they showed differential expression of CD1a, CD1b, CD1c, CD11b, CD206 and CD207 markers when compared with each other. Cell differentiation into DC was significantly inhibited by an anti‐TNF‐α nonoclonal antibody. The CD11c+ CD14– subset was isolated and shown to be more potent in stimulating an alloreaction than the CD11c+ CD14+ subset. Collectively, these data highlight the differential effects of TLR agonists on human bone marow CD34+ progenitor cells and provide a new opportunity for generating functional DC that would be useful in cancer vaccination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.200737112

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 83

Metadata

Authors
Sioud, M., & Fløisand, Y.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2007-09-26
Volume
37
Issue
10
Pages
2834-2846
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2050628678
Cited by
83
References
2
FWCI
1.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type response. https://app.cochat.ai/papers/10.1002/eji.200737112
The paper
Sioud, M., & Fløisand, Y. (2007). TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type response. European Journal of Immunology. https://doi.org/10.1002/eji.200737112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.